Heath Lukatch
CIK 1596385 · last filed 2025-06-16
Heath Lukatch is a corporate insider who has filed 45 SEC Form 4 insider transactions across 4 companies since 2015. The most recent filing, for PCVX, was dated Jun 16, 2025. Across all open-market trades the lifetime net is −$4.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $898.8K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$898.8K
4
45
-$4.15M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PCVX | Director | 17,216 | $47.46 | $817.1K | -$1.94M | 14 | 2025-06-16 |
| Satsuma Pharmaceuticals, Inc. (STSA) Delisted | Director | — | $1.10 | — | $0 | 5 | 2023-06-08 |
| FLXN | Director | 0 | $25.05 | $0 | $0 | 7 | 2021-11-19 |
| INGN | Director | 12,775 | $6.40 | $81.8K | -$2.20M | 19 | 2021-05-12 |
Recent Filings
45 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-06-16 | PCVX | Grant (A) | +3,041 | $0 | EDGAR |
| 2025-04-10 | PCVX | Exer (M) | +7,000 | $117.5K | EDGAR |
| 2024-06-10 | PCVX | Grant (A) | +1,550 | $0 | EDGAR |
| 2024-02-02 | PCVX | Mixed | — | -$277.5K | EDGAR |
| 2024-01-31 | PCVX | Mixed | — | -$206.0K | EDGAR |
| 2024-01-04 | PCVX | Mixed | — | -$620.9K | EDGAR |
| 2023-06-15 | PCVX | Grant (A) | +2,500 | $0 | EDGAR |
| 2023-06-08 | Satsuma Pharmaceuticals, Inc. (STSA) Delisted | Disp (D) | — | $0 | EDGAR |
| 2023-01-12 | PCVX | Mixed | — | -$9.5K | EDGAR |
| 2022-12-14 | PCVX | Mixed | — | -$9.4K | EDGAR |